跳至主要内容
临床试验/NCT04005521
NCT04005521进行中(未招募)不适用

Preventive Randomized Study Regarding Jaw- and Swallowing Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer: the Effect of Preventive Intervention for Trismus, Swallowing Function and Quality of Life

Sahlgrenska University Hospital, Sweden2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年6月13日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
80
试验地点
2
主要终点
Maximal Interincisal opening (MIO)

研究概览

简要总结

The study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive jaw- and swallowing exercise protocol before and during radiotherapy) or a control group no performing a exercise protocol. All patients will be encouraged to eat or drink for as long as possible during the therapy. All patients will meet with a speech-language therapist weekly during radiotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx)
  • Receiving radiohterpay (+/- chemotherapy) with curative intent
  • No previous trismus or dysphagia

排除标准

  • Surgery due to head and neck cancer
  • Previous treatment for head and neck cancer
  • Tracheostomized patients
  • Inability to perform exercise intervention
  • Inability to independently fill out questionnaires in Swedish
  • Previous neurologic or neuromuscular disease

结局指标

主要结局

Maximal Interincisal opening (MIO)

时间窗: 1 month post radiotherapy

Jaw opening measured in millimeters. A MIO \<36 mm is considered as trismus. i.e. limited jaw-opening.

Swallowing ability

时间窗: 1 month after radiotherapy

Swallowing ability measured with Functional Endoscopic Examination of Swallowing (FEES)

次要结局

  • Maximal Interincisal opening (MIO)(Up to 5 years post radiotherapy)
  • Swallowing ability(Up to 5 years post radiotherapy)
  • Dysphagia related symtoms(Up to 5 years post radiotherapy)
  • Trismus and jaw related symptoms(Up to 5 years post radiotherapy)
  • Health related quality of life (HRQL)(Up to 5 years post radiotherapy)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Tuomi

Principal Investigator

Vastra Gotaland Region

研究点 (2)

Loading locations...

相似试验